
Sign up to save your podcasts
Or
Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.
Find our substack and all promotional links here:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
4.9
280280 ratings
Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.
Find our substack and all promotional links here:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
336 Listeners
1,225 Listeners
49 Listeners
85 Listeners
1,657 Listeners
390 Listeners
224 Listeners
200 Listeners
32 Listeners
94 Listeners
71 Listeners
157 Listeners
19 Listeners
25 Listeners
20 Listeners